NVO News and Press, Novo Nordisk A/S From 05/03/24

2024-05-03 09:26:24 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent gains after filing 10-Q FTC likely to look at Catalent alternatives in review of Novo deal - report Seeking Alpha’s Quant Rating on Catalent His...

2024-05-03 07:00:00 ET Novo Nordisk 's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a diabetes treatment, while the latter is its fast-growing weight-loss drug. Both are comparable and have been associated with helping people lose significant bod...

2024-05-02 17:40:21 ET More on Amgen Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Amgen Non-GAAP EPS of $3.96 beats by $0.05, revenue of $7.45B in-line ...

2024-05-02 14:35:00 ET Summary Barry McCarthy steps down as CEO, president, and board director of Peloton. Q1 nonfarm productivity crept up 0.3% Q/Q; Initial jobless claims steady 208k for the week. Crowd Sentiment Poll ended its third-longest streak of optimism since 1995 - N...

2024-05-02 13:00:13 ET Image source: The Motley Fool. Novo Nordisk (NYSE: NVO) Q1 2024 Earnings Call May 02, 2024 , 7:00 a.m. ET Operator Continue reading For further details see: Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript

2024-05-02 12:21:14 ET Novo Nordisk A/S (NVO) Q1 2024 Earnings Conference Call May 2, 2024 07:00 a.m. ET Company Participants Lars Fruergaard Jørgensen - Chief Executive Officer Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corpor...

2024-05-02 10:18:21 ET The biotech sector includes companies that utilize biological processes to develop technologies and products for a wide range of industries. This includes healthcare, agriculture, and environmental management. These companies often focus on innovative therapies, medic...

2024-05-02 09:58:32 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly Shoots Higher: It's Time To Be Cautious Eli Lilly: The GLP-1 Wonder Continues, A Bullish Beat And Raise Eli Lilly: Management Raises 2024 Guidance, Driven By GLP-1 Franchise Novo Nordisk s...

2024-05-02 09:17:44 ET More on Novo Nordisk Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo Nordisk lifts guidance as Ozempic,...

2024-05-02 09:11:00 ET U.S. stock index futures on Thursday pointed to a higher open, a day after the Federal Reserve and chair Jerome Powell were widely perceived to be much more dovish than expected. Here are some stocks to watch on Thursday: ... Read the full article on Se...